Clinical trial

Prospective, Multi-Center, Random. Study of CoStar Paclitaxel-Eluting Coronary…

NCT00440674 · Conor Medsystems, Industry · Terminated

Key facts

NCT number NCT00440674
Title Prospective, Multi-Center, Random. Study of CoStar Paclitaxel-Eluting Coronary Stent(Direct Stenting vs. Pre-Dilatation)
Official title The DECIDE Trial: Prospective, Multi-center, Randomized Study to Evaluate the CoStar Paclitaxel-Eluting Coronary Stent System Using a Direct Stenting Technique Compared to Conventional Stenting With Pre-dilatation Strategy
Acronym DECIDE
Lead sponsor Conor Medsystems, Industry
Status Terminated
Phase Phase 4
Study type Interventional
Conditions Coronary Artery Disease
Intervention type Device
Interventions CoStar Paclitaxel-eluting coronary stent system
Enrollment 18
Start date Feb 1, 2007
Primary completion Jun 1, 2007
Completion Jul 1, 2009
First posted Feb 27, 2007
Last update posted Oct 30, 2009
Countries Germany

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies